These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


875 related items for PubMed ID: 25989844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men.
    Estévez-Lamorte N, Foster S, Eich-Höchli D, Moggi F, Gmel G, Mohler-Kuo M.
    Eur Arch Psychiatry Clin Neurosci; 2019 Sep; 269(6):667-679. PubMed ID: 30483874
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men.
    Vogel T, Dom G, van de Glind G, Studer J, Gmel G, Strik W, Moggi F.
    Addiction; 2016 Oct; 111(10):1867-78. PubMed ID: 27061514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ, van der Maas M, Toplak ME, Erickson PG, Mann RE, Seeley J, Vingilis E.
    BMC Psychiatry; 2016 Feb 27; 16():50. PubMed ID: 26920911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T, Agerbo E, Horsdal HT, Ottosen C, Brikell I, Als TD, Demontis D, Børglum AD, Nordentoft M, Mors O, Werge T, Hougaard D, Bybjerg-Grauholm J, Hansen MB, Mortensen PB, Thapar A, Riglin L, Langley K, Dalsgaard S.
    Addiction; 2020 Jul 27; 115(7):1368-1377. PubMed ID: 31803957
    [Abstract] [Full Text] [Related]

  • 11. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH.
    Curr Med Res Opin; 2008 May 27; 24(5):1345-57. PubMed ID: 18384709
    [Abstract] [Full Text] [Related]

  • 12. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ, McGue M, Iacono WG.
    Arch Gen Psychiatry; 2007 Oct 27; 64(10):1145-52. PubMed ID: 17909126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC, Bisgaard C.
    Eur Neuropsychopharmacol; 2014 Feb 27; 24(2):232-41. PubMed ID: 24314850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV.
    Addiction; 2013 Aug 27; 108(8):1503-11. PubMed ID: 23506232
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.